Literature DB >> 29435846

Psychosocial Needs of Head and Neck Cancer Patients and the Role of the Clinical Social Worker.

Natalie Thome1, Nellie Garcia2, Karen Clark2.   

Abstract

In this chapter, we examine the demographics and risk factors in the population diagnosed with head and neck cancer (HNC), what challenges these patients face post-treatment and what the role of psychosocial support through clinical social work is in managing these stressors. While many forms of head and neck cancer found in the early stages have a high cure rate, the side effects of treatment for these cancers have major life-altering effects. Previously, the majority of those diagnosed with head and neck cancers were those who used excessive alcohol and tobacco, but the numbers are changing to include the human papillomavirus (HPV) as a major risk factor. Due to the behavioral risk factors that are often causes of head and neck cancers and the effects of treatment that often lend to psychosocial distress, the role of psychosocial intervention at time of diagnosis throughout the disease trajectory is essential for compliance with treatment and healthy coping post-treatment. Clinical social workers play an essential role within the multidisciplinary team of assessment and interventions for managing patient's psychosocial distress.

Entities:  

Keywords:  Anxiety; Clinical social work; Cognitive behavioral therapy; Depression; Head and neck cancer; Psychosocial distress; SupportScreen

Mesh:

Year:  2018        PMID: 29435846     DOI: 10.1007/978-3-319-65421-8_14

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  2 in total

1.  Description, characterization, and evaluation of an online social networking community: the American Cancer Society's Cancer Survivors Network®.

Authors:  E A Fallon; D Driscoll; T S Smith; K Richardson; K Portier
Journal:  J Cancer Surviv       Date:  2018-08-06       Impact factor: 4.442

2.  Psychosocial and clinical predictors of patient satisfaction with cancer care.

Authors:  Fahad D Alosaimi; Futoon S Alsaleh; Luluh Y Alsughayer; Lamees A Altamimi; Ibrahim A Alfurayh; Nashwa M Abdel-Aziz; Khalid A Alsaleh
Journal:  Saudi Pharm J       Date:  2022-01-29       Impact factor: 4.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.